41480 Federal Register / Vol. 65, No. 129 / Wednesday, July 5, 2000 / Notices

made by American Indians and Alaska

Natives and to individuals recruited

through the efforts of Indian tribes or

tribal or Indian organizations.

• Funds appropriated for the LRP in

FY 2000 will be distributed among the

health professions as follows:

Allopathic/osteopathic practitioners

will receive 30 percent, registered

nurses 15 percent, mental health

professionals 10 percent, dentists 15

percent, pharamacists 12.5 percent,

optometrists 7.5 percent, physician

assistants 5 percent, other professions 5

percent. This requirement does not

apply if the number of applicants from

these groups, respectively, is not

sufficient to meet the requirement.

• The IHS will give priority in

funding among health professionals to

physicians in the following priority

specialities: anesthesiology, emergency

room medicine, general surgery,

obstetrics/gynecology, ophthalmology,

orthopedic surgery, otolaryngology/

otorhinolaryngology, psychiatry,

radiology and dentistry. Funding for

these priority specialities is within the

30 percent established for allopathic/

osteopathic practitioners.

The following factors are equal in

weight when applied, and are applied

when all other criteria are equal and a

selection must be made between

applicants.

One or all of the following factors may

be applicable to an applicant, and the

applicant who has the most of these

factors, all other criteria being equal,

would be selected.

• An applicant’s length of current

employment in the IHS, tribal, or urban

program.

• Availability for service earlier than

other applicants (first come, first

served); and

• Date the individual’s application

was received.

Any individual who enters this

program and satisfactorily completes his

or her obligated period of service may

apply to extend his/her contract on a

year-by-year basis, as determined by the

IHS. Participants extending their

contracts will receive up to the

maximum amount of $20,000 per year

plus an additional 20 percent for

Federal Withholding. Participants who

were awarded loan repayment contracts

prior to FY 2000 will be awarded

extensions up to the amount of $30,000

a year and 31 percent in tax subsidy if

funds are available, and will not exceed

the total of the individual’s outstanding

eligible health profession educational

loans.

Any individual who owes an

obligation for health professional

service to the Federal Government, a

State, or other entity is not eligible for

the Loan Repayment Program unless the

obligation will be completely satisfied

before they begin service under this

program.

The IHS Area Offices and Service

Units are authorized to provide

additional funding to make awards to

applicants in the LRP, but must be in

compliance with any limits in the

appropriation and Section 108 of the

Indian Health Care Improvement Act

not to exceed the amount authorized in

the IHS appropriation (up to

$17,000,000 for FY 2000.) Federally

recognized tribes are also authorized to

provide funding to make supplemental

awards to participants who are tribal

employees. Civil Service or Commission

Corps employees are ineligible because

it would violate 18 U.S.C. 209(a). The

funding source cannot be from

appropriated monies pursuant to the

Indian Self Determination and

Education Assistant Act (ISDEA) or

other Federal funds. Tribes who elect to

provide additional monies must provide

certification in writing that the funds

are not from Federal appropriations.

Should an IHS Area Office contribute

to the LRP, those funds will be used for

only those sites located in that Area.

Those sites will retain their relative

ranking from the national site-ranking

list. For example, the Albuquerque Area

Office identifies supplemental monies

for dentists. Only the dental positions

within the Albuquerque Area will be

funded with the supplemental monies

consistent with the national ranking and

site index within that Area.

Should an IHS Service Unit

contribute to the LRP, those funds will

be used for only those sites located in

that service unit. These sites will retain

their relative ranking from the national

site-ranking list. For example, Chinle

Service Unit identifies supplemental

monies for nurses. The Chinle service

units consist of two facilities, namely

the Chinle Comprehensive Health Care

Facility and the Tsaile PHS Indian

Health Center. The national ranking will

be used for the Chinle Comprehensive

Health Care Facility (Score = 63) and the

Tsaile PHS Indian Health Center (Score

= 46). With a score of 63, the Chinle

Comprehensive Health Care Facility

would receive priority over the Tsaile

PHS Indian Health Center.

The IHS is authorized to accept

contributions from tribes to supplement

the LRP according to the IHS’s

conditional gift acceptance authority.

The Director of IHS will accept these

gifts on a case-by-case basis using the

following criteria: (1) The contribution

is not from prohibited 638 funds or

federally appropriate funds; (2) the LRP

applicant selection and placement is

consistent with the national ranking

criteria; (3) the extent to which the gift

is related to the agency’s mission for the

loan repayment program; (4) whether

the gift would benefit the agency, or

instead primarily benefit an individual

employee; and (5) the size and nature of

the gift.

This program is not subject to review

under Executive Order 12372.

The Catalog of Federal Domestic

Assistance number if 93.164.

Dated: June 28, 2000.

Michel E. Lincoln,

Deputy Director.

[FR Doc. 00–16875 Filed 7–4–00; 8:45 am]

BILLING CODE 4160–16–M

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

Substance Abuse and Mental Health

Services Administration

Current List of Laboratories Which

Meet Minimum Standards To Engage in

Urine Drug Testing for Federal

Agencies and Laboratories That Have

Withdrawn From the Program

AGENCY: Substance Abuse and Mental

Health Services Administration, HHS.

ACTION: Notice.

SUMMARY: The Department of Health and

Human Services notifies Federal

agencies of the laboratories currently

certified to meet standards of Subpart C

of Mandatory Guidelines for Federal

Workplace Drug Testing Programs (59

FR 29916, 29925). A similar notice

listing all currently certified laboratories

will be published during the first week

of each month, and updated to include

laboratories which subsequently apply

for and complete the certification

process. If any listed laboratory’s

certification is totally suspended or

revoked, the laboratory will be omitted

from updated lists until such time as it

is restored to full certification under the

Guidelines.

If any laboratory has withdrawn from

the National Laboratory Certification

Program during the past month, it will

be listed at the end, and will be omitted

from the monthly listing thereafter.

This Notice is available on the

internet at the following website:

http://wmcare.samhsa.gov.

FOR FURTHER INFORMATION CONTACT: Mrs.

Giselle Hersh or Dr. Walter Vogl,

Division of Workplace Programs, 5600

Fishers Lane, Rockwall 2 Building,

Room 815, Rockville, Maryland 20857;

Tel.: (301) 443–6014, Fax: (301) 443–

3031.

Federal Register / Vol. 65, No. 129 / Wednesday, July 5, 2000 / Notices 41481

*The Standards Council of Canada (SCC) voted

to end its Laboratory Accreditation Program for

Substance Abuse (LAPSA) effective May 12, 1998.

Laboratories certified through that program were

accredited to conduct forensic urine drug testing as

required by U.S. Department of Transportation

(DOT) regulations. As of that date, the certification

of those accredited Canadian laboratories will

continue under DOT authority. The responsibility

for conducting quarterly performance testing plus

periodic on-site inspections of those LAPSAaccredited laboratories was transferred to the U.S.

DHHS, with the DHHS’ National Laboratory

Certification Program (NLCP) contractor continuing

to have an active role in the performance testing

and laboratory inspection processes. Other

Canadian laboratories wishing to be considered for

the NLCP may apply directly to the NLCP

contractor just as U.S. laboratories do.

Special Note: Please use the above

address for all surface mail and

correspondence. For all overnight mail

service use the following address:

Division of Workplace Programs, 5515

Security Lane, Room 815, Rockville,

Maryland 20852.

SUPPLEMENTARY INFORMATION:

Mandatory Guidelines for Federal

Workplace Drug Testing were developed

in accordance with Executive Order

12564 and section 503 of Pub. L. 100–

71. Subpart C of the Guidelines,

‘‘Certification of Laboratories Engaged

in Urine Drug Testing for Federal

Agencies,’’ sets strict standards which

laboratories must meet in order to

conduct urine drug testing for Federal

agencies. To become certified an

applicant laboratory must undergo three

rounds of performance testing plus an

on-site inspection. To maintain that

certification a laboratory must

participate in a quarterly performance

testing program plus periodic, on-site

inspections.

Laboratories which claim to be in the

applicant stage of certification are not to

be considered as meeting the minimum

requirements expressed in the HHS

Guidelines. A laboratory must have its

letter of certification from SAMHSA,

HHS (formerly: HHS/NIDA) which

attests that it has met minimum

standards.

In accordance with Subpart C of the

Guidelines, the following laboratories

meet the minimum standards set forth

in the Guidelines:

ACL Laboratories, 8901 W. Lincoln

Ave., West Allis, WI 53227, 414–328–

7840/800–877–7016 (Formerly:

Bayshore Clinical Laboratory)

Advanced Toxicology Network, 3560

Air Center Cove, Suite 101, Memphis,

TN 38118, 901–794–5770/888–290–

1150

Aegis Analytical Laboratories, Inc., 345

Hill Ave., Nashville, TN 37210, 615–

255–2400

Alabama Reference Laboratories, Inc.,

543 South Hull St., Montgomery, AL

36103, 800–541–4931/334–263–5745

Alliance Laboratory Services, 3200

Burnet Ave., Cincinnati, OH 45229,

513–585–9000 (Formerly: Jewish

Hospital of Cincinnati, Inc.)

American Medical Laboratories, Inc.,

14225 Newbrook Dr., Chantilly, VA

20151, 703–802–6900

Associated Pathologists Laboratories,

Inc., 4230 South Burnham Ave., Suite

250, Las Vegas, NV 89119–5412, 702–

733–7866/800–433–2750

Baptist Medical Center—Toxicology

Laboratory, 9601 I–630, Exit 7, Little

Rock, AR 72205–7299, 501–202–2783

(Formerly: Forensic Toxicology

Laboratory Baptist Medical Center)

Clinical Reference Lab, 8433 Quivira

Rd., Lenexa, KS 66215–2802, 800–

445–6917

Cox Health Systems, Department of

Toxicology, 1423 North Jefferson

Ave., Springfield, MO 65802, 800–

876–3652/417–269–3093 (Formerly:

Cox Medical Centers)

Dept. of the Navy, Navy Drug Screening

Laboratory, Great Lakes, IL, Building

38–H, P. O. Box 88–6819, Great Lakes,

IL 60088–6819, 847–688–2045/847–

688–4171

Diagnostic Services Inc., dba DSI, 12700

Westlinks Drive, Fort Myers, FL

33913, 941–561–8200/800–735–5416

Doctors Laboratory, Inc., P.O. Box 2658,

2906 Julia Dr., Valdosta, GA 31602,

912–244–4468

DrugProof, Division of Dynacare/

Laboratory of Pathology, LLC 1229

Madison St., Suite 500, Nordstrom

Medical Tower, Seattle, WA 98104,

206–386–2672/800–898–0180

(Formerly: Laboratory of Pathology of

Seattle, Inc., DrugProof, Division of

Laboratory of Pathology of Seattle,

Inc.)

DrugScan, Inc., P.O. Box 2969, 1119

Mearns Rd., Warminster, PA 18974,

215–674–9310

Dynacare Kasper Medical Laboratories ,*

14940–123 Ave., Edmonton, Alberta,

Canada T5V 1B4, 780–451–3702/800–

661–9876

ElSohly Laboratories, Inc., 5 Industrial

Park Dr., Oxford, MS 38655, 662–236–

2609

Gamma-Dynacare Medical

Laboratories *, A Division of the

Gamma-Dynacare Laboratory

Partnership, 245 Pall Mall St.,

London, ONT, Canada N6A 1P4, 519–

679–1630

General Medical Laboratories, 36 South

Brooks St., Madison, WI 53715, 608–

267–6267

Hartford Hospital Toxicology

Laboratory, 80 Seymour St., Hartford,

CT 06102–5037, 860–545–6023

Integrated Regional Laboratories, 5361

NW 33rd Avenue, Fort Lauderdale, FL

33309, 954–777–0018, 800–522–0232

(Formerly: Cedars Medical Center,

Department of Pathology)

Kroll Laboratory Specialists, Inc., 1111

Newton St., Gretna, LA 70053, 504–

361–8989/800–433–3823 (Formerly:

Laboratory Specialists, Inc.)

LabOne, Inc., 10101 Renner Blvd.,

Lenexa, KS 66219, 913–888–3927/

800–728–4064 (Formerly: Center for

Laboratory Services, a Division of

LabOne, Inc.)

Laboratory Corporation of America

Holdings, 1904 Alexander Drive,

Research Triangle Park, NC 27709,

919–572–6900/800–833–3984

(Formerly: LabCorp Occupational

Testing Services, Inc., CompuChem

Laboratories, Inc.; CompuChem

Laboratories, Inc., A Subsidiary of

Roche Biomedical Laboratory; Roche

CompuChem Laboratories, Inc., A

Member of the Roche Group)

Laboratory Corporation of America

Holdings, 4022 Willow Lake Blvd.,

Memphis, TN 38118, 901–795–1515/

800–233–6339 (Formerly: LabCorp

Occupational Testing Services, Inc.,

MedExpress/National Laboratory

Center)

Laboratory Corporation of America

Holdings, 69 First Ave., Raritan, NJ

08869, 908–526–2400/800–437–4986

(Formerly: Roche Biomedical

Laboratories, Inc.)

Marshfield Laboratories, Forensic

Toxicology Laboratory, 1000 North

Oak Ave., Marshfield, WI 54449, 715–

389–3734/800–331–3734

MAXXAM Analytics Inc. *, 5540

McAdam Rd., Mississauga, ON,

Canada L4Z 1P1, 905–890–2555

(Formerly: NOVAMANN (Ontario)

Inc.)

Medical College Hospitals Toxicology

Laboratory, Department of Pathology,

3000 Arlington Ave., Toledo, OH

43699, 419–383–5213

MedTox Laboratories, Inc., 402 W.

County Rd. D, St. Paul, MN 55112,

651–636–7466/800–832–3244

MetroLab-Legacy Laboratory Services,

1225 NE 2nd Ave., Portland, OR

97232, 503–413–5295/800–950–5295

Minneapolis Veterans Affairs Medical

Center, Forensic Toxicology

Laboratory, 1 Veterans Drive,

Minneapolis, Minnesota 55417, 612–

725–2088

National Toxicology Laboratories, Inc.,

1100 California Ave., Bakersfield, CA

93304, 661–322–4250/800–350–3515

NWT Drug Testing, 1141 E. 3900 South,

Salt Lake City, UT 84124, 801–293–

2300/800–322–3361 (Formerly:

NorthWest Toxicology, Inc.)

One Source Toxicology Laboratory, Inc.,

1705 Center Street, Deer Park, TX

77536, 713–920–2559 (Formerly:

41482 Federal Register / Vol. 65, No. 129 / Wednesday, July 5, 2000 / Notices

University of Texas Medical Branch,

Clinical Chemistry Division; UTMB

Pathology-Toxicology Laboratory)

Oregon Medical Laboratories, P.O. Box

972, 722 East 11th Ave., Eugene, OR

97440–0972, 541–687–2134

Pacific Toxicology Laboratories, 6160

Variel Ave., Woodland Hills, CA

91367, 818–598–3110/800–328–6942

(Formerly: Centinela Hospital Airport

Toxicology Laboratory)

Pathology Associates Medical

Laboratories, 11604 E. Indiana Ave.,

Spokane, WA 99206, 509–926–2400/

800–541–7891

PharmChem Laboratories, Inc., 1505–A

O’Brien Dr., Menlo Park, CA 94025,

650–328–6200/800–446–5177

PharmChem Laboratories, Inc., Texas

Division, 7606 Pebble Dr., Fort Worth,

TX 76118, 817–215–8800 (Formerly:

Harris Medical Laboratory)

Physicians Reference Laboratory, 7800

West 110th St., Overland Park, KS

66210, 913–339–0372/800–821–3627

Poisonlab, Inc., 7272 Clairemont Mesa

Blvd., San Diego, CA 92111, 858–279–

2600/800–882–7272

Quest Diagnostics Incorporated, 3175

Presidential Dr., Atlanta, GA 30340,

770–452–1590 (Formerly: SmithKline

Beecham Clinical Laboratories,

SmithKline Bio-Science Laboratories)

Quest Diagnostics Incorporated, 4444

Giddings Road, Auburn Hills, MI

48326, 248–373–9120/800–444–0106

(Formerly: HealthCare/Preferred

Laboratories, HealthCare/MetPath,

CORNING Clinical Laboratories)

Quest Diagnostics Incorporated,

National Center for Forensic Science,

1901 Sulphur Spring Rd., Baltimore,

MD 21227, 410–536–1485 (Formerly:

Maryland Medical Laboratory, Inc.,

National Center for Forensic Science,

CORNING National Center for

Forensic Science)

Quest Diagnostics Incorporated, 8000

Sovereign Row, Dallas, TX 75247,

214–638–1301 (Formerly: SmithKline

Beecham Clinical Laboratories,

SmithKline Bio-Science Laboratories)

Quest Diagnostics Incorporated, 4770

Regent Blvd., Irving, TX 75063, 972–

916–3376/800–526–0947 (Formerly:

Damon Clinical Laboratories, Damon/

MetPath, CORNING Clinical

Laboratories)

Quest Diagnostics Incorporated, 801

East Dixie Ave., Leesburg, FL 34748,

352–787–9006 (Formerly: SmithKline

Beecham Clinical Laboratories,

Doctors & Physicians Laboratory)

Quest Diagnostics Incorporated, 400

Egypt Rd., Norristown, PA 19403,

610–631–4600/800–877–7484

(Formerly: SmithKline Beecham

Clinical Laboratories, SmithKline BioScience Laboratories)

Quest Diagnostics Incorporated, 506 E.

State Pkwy., Schaumburg, IL 60173,

800–669–6995/847–885–2010

(Formerly: SmithKline Beecham

Clinical Laboratories, International

Toxicology Laboratories)

Quest Diagnostics Incorporated, 7470

Mission Valley Rd., San Diego, CA

92108–4406, 619–686–3200/800–446–

4728, (Formerly: Nichols Institute,

Nichols Institute Substance Abuse

Testing (NISAT), CORNING Nichols

Institute, CORNING Clinical

Laboratories)

Quest Diagnostics Incorporated, One

Malcolm Ave., Teterboro, NJ 07608,

201–393–5590 (Formerly: MetPath,

Inc., CORNING MetPath Clinical

Laboratories, CORNING Clinical

Laboratory)

Quest Diagnostics Incorporated, 7600

Tyrone Ave., Van Nuys, CA 91405,

818–989–2520/800–877–2520

(Formerly: SmithKline Beecham

Clinical Laboratories)

San Diego Reference Laboratory, 6122

Nancy Ridge Dr., San Diego, CA

92121, 800–677–7995/858–677–7970

Scientific Testing Laboratories, Inc., 463

Southlake Blvd., Richmond, VA

23236, 804–378–9130

Scott & White Drug Testing Laboratory,

600 S. 25th St., Temple, TX 76504,

254–771–8379/800–749–3788

S.E.D. Medical Laboratories, 5601 Office

Blvd., Albuquerque, NM 87109, 505–

727–6300/800–999–5227

South Bend Medical Foundation, Inc.,

530 N. Lafayette Blvd., South Bend,

IN 46601, 219–234–4176

Southwest Laboratories, 2727 W.

Baseline Rd., Tempe, AZ 85283, 602–

438–8507/800–279–0027

Sparrow Health System, Toxicology

Testing Center, St. Lawrence Campus,

1210 W. Saginaw, Lansing, MI 48915,

517–377–0520 (Formerly: St.

Lawrence Hospital & Healthcare

System)

St. Anthony Hospital Toxicology

Laboratory, 1000 N. Lee St.,

Oklahoma City, OK 73101, 405–272–

7052

Toxicology & Drug Monitoring

Laboratory, University of Missouri

Hospital & Clinics, 2703 Clark Lane,

Suite B, Lower Level, Columbia, MO

65202, 573–882–1273

Toxicology Testing Service, Inc., 5426

N.W. 79th Ave., Miami, FL 33166,

305–593–2260

UNILAB, 18408 Oxnard St., Tarzana,

CA 91356, 818–996–7300/800–339–

4299 (Formerly: MetWest-BPL

Toxicology Laboratory)

Universal Toxicology Laboratories, LLC,

10210 W. Highway 80, Midland,

Texas 79706, 915–561–8851/888–

953–8851

Upon finding a Canadian laboratory to

be qualified, the DHHS will recommend

that DOT certify the laboratory (Federal

Register, 16 July 1996) as meeting the

minimum standards of the ‘‘Mandatory

Guidelines for Workplace Drug Testing’’

(59 Federal Register, 9 June 1994, Pages

29908–29931). After receiving the DOT

certification, the laboratory will be

included in the monthly list of DHHS

certified laboratories and participate in

the NLCP certification maintenance

program.

Richard Kopanda,

Executive Officer, Substance Abuse and

Mental Health Services Administration.

[FR Doc. 00–16851 Filed 7–3–00; 8:45 am]

BILLING CODE 4160–20–P

DEPARTMENT OF HOUSING AND

URBAN DEVELOPMENT

[Docket No. FR–4566 N–07]

Notice of Proposed Information

Collection: Comment Request, 2000

Survey of Homeless Residential

Service Providers

AGENCY: Office of the Assistant

Secretary for Community Planning and

Development, HUD.

ACTION: Notice.

SUMMARY: The Proposed information

collection requirement described below

will be submitted to the Office of

Management and Budget (OMB) for

review, as required by the Paperwork

Reduction Act. The Department is

soliciting public comments on the

subject proposal.

DATES: Comment Due Date: September

5, 2000.

ADDRESSES: Interested persons are

invited to submit comments regarding

this proposal. Comments should refer to

the proposal by name and/ or OMB

Control Number and should be sent to:

Sheila Jones, Reports Liaison Officer,

Department of Housing and Urban

Development, 451 7th Street, SW.,

Room 7232, Washington, DC 20410

FOR FURTHER INFORMATION CONTACT: Mr.

Michael Roanhouse (202) 708–1226

telephone number (this is not a toll-free

number).

SUPPLEMENTARY INFORMATION: The

Department is submitting the proposed

information collection to OMB for

review, as required by the Paperwork

Reduction Act of 1995 (44 U.S.C.

Chapter 35, as amended).

This Notice is soliciting comments

from members of the public and

affecting agencies concerning the

proposed collection of information to: